Johnson & Johnson Secures Regulatory Approvals for Stelara and Psoriasis Drug

Johnson & Johnson has secured regulatory approvals expanding Stelara’s use to treat pediatric ulcerative colitis and launching an oral psoriasis treatment in China. These milestones broaden the pharmaceutical company’s therapeutic portfolio across key markets.